SCAI/ACC/HRS Institutional and Operator Requirements for Left Atrial Appendage Occlusion

[...]there is agreement that non-pharmacologic treatment for stroke prevention has been an unmet need, which has stimulated the development of alternatives to pharmacologic therapies. [...]it is essential that stakeholders have a thorough understanding of the cognitive and technical aspects surround...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2016-05, Vol.67 (19), p.2295-2305
Main Authors: Kavinsky, Clifford J., MD, PhD, FACC, FSCAI, Kusumoto, Fred M., MD, FACC, FHRS, Bavry, Anthony A., MD, MPH, FACC, Bailey, Steven R., MD, FACC, MSCAI, Ellenbogen, Kenneth A., MD, FACC, FHRS, Hess, Paul L., MD, MHS, Lustgarten, Daniel L., MD, PhD, FACC, FHRS, Moussa, Issam D., MD, FACC, FSCAI, Spies, Christian, MD, FACC, FSCAI
Format: Article
Language:English
Subjects:
Anticoagulants
Atrial Appendage - surgery
atrial fibrillation
Atrial Fibrillation - complications
Atrial Fibrillation - surgery
Cardiology
Cardiovascular
Catheters
FDA approval
Heart surgery
Humans
Internal Medicine
Occlusion
Stroke
Stroke - etiology
Stroke - prevention & control
structural heart disease
Therapeutic Occlusion - instrumentation
Therapeutic Occlusion - standards
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]there is agreement that non-pharmacologic treatment for stroke prevention has been an unmet need, which has stimulated the development of alternatives to pharmacologic therapies. [...]it is essential that stakeholders have a thorough understanding of the cognitive and technical aspects surrounding LAA occlusion in general and the various technologies for LAA occlusion currently available and in development.Cognitive Requirements Percutaneous LAA occlusion is a new technique, and a significant learning curve for deployment of the WATCHMAN device has demonstrated reduced procedure time, decreased complications, and improved procedural success rates with increasing operator experience (9,10). Centers without an on-site cardiothoracic surgery service available and ready for emergent operation should not have an LAA occlusion implant program. Besides tamponade, the management team must monitor the patient for other complications, including procedure-related stroke, air embolus, and device embolization, all of which are mitigated by sophisticated handling of the sheath delivery system and the anticoagulation status of the patient during the procedure. [...]proctors who are experienced in LAA occlusion with a specific device should be present to monitor the initial implants performed by the procedural specialist.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.12.001